arrow
M

Marc Bardou

clinical epidemiology/clinical trials unit
H指数:44
被引数:9,160

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Reply to “Preclinical and Clinical Evidence on Chloroquine or Hydroxychloroquine in COVID-19”: Achieving Statistical Significance Does Not Mean That Clinical Relevance Can Be Disregarded, and This Must Be Considered When Interpreting Results

回复“关于COVID-19中氯喹或羟氯喹的预临床和临床证据”:达到统计学显著性并不意味着临床相关性可以被忽视,并且在解释结果时必须考虑这一点

2026-06-020
OA
CONVICTION-CHIK study on the effect of convalescent plasma for mother-to-child Chikungunya infection: protocol for a multicentre, open label, single-arm, phase II trial

CONVICTION-CHIK研究:康复血浆对母婴传播奇坎贡亚病毒感染的影响——一项多中心、开放标签、单臂、II期试验方案

2026-05-220
OA
Immunogenicity and Safety of Beta-Adjuvanted Recombinant Booster Vaccine
2022-07-2841
OAAI
Safety and efficacy of low-dose PI3K inhibitor taselisib in adult patients with CLOVES and Klippel-Trenaunay syndrome (KTS): the TOTEM trial, a phase 1/2 multicenter, open-label, single-arm study
2021-12-0111
OAAI
Efficacy, safety and outcomes of transcatheter arterial embolization with N-butyl cyanoacrylate glue for non-variceal gastrointestinal bleeding: A systematic review and meta-analysis

氰基丙烯酸正丁酯经导管动脉栓塞治疗非静脉曲张性消化道出血的疗效、安全性和预后的系统评价和meta分析

2021-07-0136
OAAI